Clinical Trial Update: IGF-1 Therapy in Patients With Cystic Fibrosis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating IGF-1 therapy in cystic fibrosis patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• IGF-1 Therapy (insulin-like growth factor 1)

Snippet

Sponsor: Stony Brook University | Conditions: Cystic Fibrosis | Phase 1 | Status: TERMINATED